Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Sep 7 - Sep 12
Disclaimer: This article reports on published clinical trial data for informational and educational purposes only
Novo Nordisk leads the sector in spending on shareholder enrichment: With a ratio of 1.41, Novo Nordisk spent 41% more on shareholder returns (buybacks and dividends) compared to R&D, making it the highest spender on shareholder enrichment among 15 peer companies 9 in the pharmaceutical sector
Avoid using Retin-A or other retinoids for at least two weeks after treatment
Homocysteine : Also elevated when B12 or folate is low [*]
As compared to delayed laparoscopic cholecystectomy, the rate of serious complications is not increased and hospital stay is shortened [139,140,141,142,143]
US$ 28.59
US$ 27.99
US$ 25.88
US$ 22.41
US$ 21.66
US$ 25.48
US$ 20.44
